MedTrace Logo

Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas

NCT00183976 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2014-05-22

No results posted yet for this study

Summary

This study is for patients who have been treated before and either the treatment did not work or the lymphoma has come back.

Conditions

  • Non-Hodgkin's Lymphoma
  • Burkitt Lymphoma
  • Primary Effusion Lymphomas

Interventions

DRUG

Pegylated Liposomal Doxorubicin (Doxil) and Rituximab

Sponsors & Collaborators

  • University of Southern California

    lead OTHER

Principal Investigators

  • Anil Tulpule, MD · University of Southern California

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2005-09-30
Completion
2006-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00183976 on ClinicalTrials.gov